Nuvaira: Funding, Investors & Team (Oct 2026)
Nuvaira is a new and innovative option for treating COPD, focusing on creating devices to help with lung diseases. They are currently developing a unique catheter system that could enhance lung function, physical endurance, and overall well-being for those with chronic obstructive pulmonary disease. Established in 2008, Nuvaira is based in Minneapolis, Minnesota.
Nuvaira has raised $35.8M across 2 funding rounds on record, the most recent an undisclosed round of $35.8M announced in Mar 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nuvaira Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Nuvaira Funding Rounds
Nuvaira raised $50k in an undisclosed round announced in May 2024.
1.8 years later, an undisclosed round of $35.8M was announced in Mar 2026.
Nuvaira Founders and Leadership Team
Contact details for the Nuvaira team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Nuvaira Funding Compared to Other Biotechnology Startups
Nuvaira's latest round of $35.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nuvaira in Biotechnology and Minneapolis
Companies Similar to Nuvaira
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nuvaira Funding FAQs
What does Nuvaira do?
Nuvaira is a new and innovative option for treating COPD, focusing on creating devices to help with lung diseases. They are currently developing a unique catheter system that could enhance lung function, physical endurance, and overall well-being for those with chronic obstructive pulmonary disease. Established in 2008, Nuvaira is based in Minneapolis, Minnesota.
How much funding has Nuvaira raised?
Nuvaira has raised $35.8M across 2 rounds on record. The most recent is an undisclosed round of $35.8M announced in Mar 2026.
When did Nuvaira last raise funding?
Nuvaira's most recent funding round on record is an undisclosed round of $35.8M, announced in Mar 2026.
Who founded Nuvaira?
FundedIQ lists Dennis Wahr (Founder), Dennis Wahr Md (Founder) at Nuvaira.
Where is Nuvaira headquartered?
Nuvaira is based in Minneapolis, Minnesota, United States.
How many employees does Nuvaira have?
Nuvaira is in the 51-100 employee band.
How does Nuvaira's funding compare to other Biotechnology startups?
Nuvaira's latest round of $35.8M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nuvaira Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nuvaira is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.